An observational study in Tobacco Smoking, Cancer and Tobacco Cessation, sponsored by Bispebjerg Hospital. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-10.
Sponsored by Bispebjerg Hospital · Observational
Smoking accounts for approximately 30% of total cancer deaths each year. Even though former studies show that persons with a cancer diagnosis are less likely to smoke than the general population up to 50% of people who smoke and have lung cancer do not stop smoking after their diagnosis or frequently relapse after smoking cessation. Continued smoking leads to increased all-cause mortality, increased cancer-specific mortality, and decreased quality of life. It is well-known that cancer patients are interested in smoking cessation therefore smoking cessation interventions play an important role in the management of people with cancer.
This study will evaluate the effectiveness of an intensive smoking cessation interventions on cancer patients in real life. The project provides new knowledge about smokers diagnosed with cancer.
This prospective register-based cohort study including smokers attending an intensive smoking cessation intervention (the Gold Standard Programme (GSP)) from 2006-2017 in Denmark. The GSP is a manualised, patient education programme taught by specially trained staff, including pharmacologic strategies.
81 studies on the registry are indexed under Tobacco Smoking; 27 are open to participants now.
This study's enrollment of 77,380 is above the median of 151 across 11 observational studies indexed under Tobacco Smoking.
Browse Tobacco Smoking studies →Bispebjerg Hospital is the lead sponsor of 289 studies on the registry; 29 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The population in this study are smokers in Denmark, with or without cancer, who are motivated to attempt to quit smoking, and have attented an intensive smoking cessation programme.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients diagnosed with cancer (with at least one of the following ICD-10 diagnoses: C00-43; C46.1-99; D09)
Behavioral: Intensive Smoking Cessation Intervention
Patients without cancer (without any of the following ICD-10 diagnoses: C00-99; D09; D30.1-9; D32-33; D35.2-4; D41.1-9; D44.3-5)
Behavioral: Intensive Smoking Cessation Intervention
The intervention comprises 5-6 meetings during six weeks, and can be held in group or as an individual intervention. It is based on counselling and a clearly structured manual-based patient education programme taught by specially trained staff, and contains individual counselling on nicotine replacement therapy or other medical support, according to the level of dependence measured by the Fagerström test score. The first two weeks cover teaching sessions on: ambivalence and motivation, pros and cons of continuous smoking versus cessation, and a quit date is set between the 2. and 3. week. The last 3 sessions cover: risk situations, withdrawal symptoms and medical support for withdrawal symptoms, relapse prevention and how to handle a completely smoke-free life.
Also known as: GSP (Gold Standard Programme for Smoking Cessation)
% of patients that are continuously smokefree
Self-reported smoking status, questionnaire completed by telephone interview
Time frame: 6 months
% of patients that are smokefree
Counsellor observed smoking status, questionnaire completed by counsellor
Time frame: Last intervention day (6 weeks post baseline)
% of patients that have been smokefree for at least the latest 14 days
Self-reported smoking status, questionnaire completed by telephone interview
Time frame: 6 months
% of patients that are satisfied with the smoking cessation intervention
Self-reported patient-satisfaction, questionnaire completed by telephone interview
Time frame: 6 months
% of patients that are compliant to the treatment
Counsellor observed meeting adherence, questionnaire completed by counsellor
Time frame: Last intervention day (6 weeks post baseline)
No study locations are listed for this record.
Plan to share: No
Ran from Jan 2006 to primary completion in Jan 2018, 144 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.